WELLINGTON MANAGEMENT GROUP LLP

Position in PRAX — Praxis Precision Medicines, Inc.

CIK 902219 Boston, MA

Position in PRAX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$56,173,823

+$4,133,943 QoQ

Shares Held

174,350

-1.3% QoQ

Ownership

0.625%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 72.81388012618297.ToString("F0")% None 27.186119873817034.ToString("F0")%

Healthcare · as of Mar 31, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $14,418,547,095 across 180 Biotechnology names. PRAX ranks #45 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,212,589	$1,434,549,489
2	REGN	Regeneron Pharmaceuticals, Inc.	1,837,459	$1,419,694,318
3	ARGX	Argenx SE	1,021,457	$745,918,971
4	ALNY	Alnylam Pharmaceuticals, Inc.	1,935,925	$640,539,501
5	RVMD	Revolution Medicines, Inc.	6,027,819	$586,205,394
6	CYTK	Cytokinetics Inc	8,009,489	$527,905,416
7	IONS	Ionis Pharmaceuticals Inc	6,391,816	$479,961,458
8	ASND	Ascendis Pharma A/S	1,757,633	$402,023,391

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$56,173,823	174,350	-1.3%	Shares	Defined	2026-05-15
2025-12-31	$52,039,880	176,562	+188.3%	Shares	Defined	2026-02-17
2025-09-30	$3,245,773	61,241	+9.6%	Shares	Defined	2025-11-14
2025-06-30	$2,349,794	55,881	+10.1%	Shares	Defined	2025-08-14
2025-03-31	$1,922,886	50,776	-20.6%	Shares	Defined	2025-05-13
2024-12-31	$4,920,359	63,934	-70.9%	Shares	Defined	2025-02-12
2024-09-30	$12,653,447	219,907	+326.9%	Shares	Defined	2024-11-14
2024-06-30	$2,130,576	51,513	+30.2%	Shares	Defined	2024-08-14
2024-03-31	$2,414,255	39,565	—	Shares	Defined	2024-05-15
No filing history on record for this holder in this stock.